Package Leaflet: Information for the Patient
Ryzodeg 100units/ml FlexTouch solution for injection in pre-filled pen
70% insulin degludec / 30% insulin aspart
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Contents of the pack:
Ryzodeg is used to treat diabetes mellitus in adults, adolescents and children from 2 years old. It helps your body to reduce the level of sugar in your blood.
This medicine contains two types of insulin:
Do not use Ryzodeg
Warnings and precautions
Talk to your doctor, pharmacist or nurse before you start using Ryzodeg. It is important that you know the following:
In case of reduced vision, see section 3.
Changes in the skin at the injection site
You should rotate the injection site to help avoid changes in the fatty tissue, such as thickening of the skin, thinning of the skin or lumps under the skin. Insulin may not work well if you inject into a lumpy, thinned or thickened area (see section 3 “How to use Ryzodeg”). Tell your doctor if you notice any changes at the injection site. Tell your doctor if you are currently injecting into these affected areas, before starting to inject into a different area. Your doctor may tell you to check your blood sugar levels more closely and adjust your insulin dose or the dose of your other anti-diabetic medicines.
Children and adolescents
Ryzodeg can be used in adolescents and children from 2 years old with diabetes mellitus. Ryzodeg should be used with special caution in children from 2 to 5 years of age. The risk of very low blood sugar levels may be higher in this age group. There is no experience with the use of this medicine in children under 2 years old.
Other medicines and Ryzodeg
Tell your doctor, pharmacist or nurse if you are using, have recently used or might use any other medicines. Some medicines affect your blood sugar level, and your insulin dose may need to be changed.
The following are the main medicines that may affect your treatment with insulin.
Your blood sugar level may decrease (hypoglycaemia) if you take:
Your blood sugar level may increase (hyperglycaemia) if you take:
Octreotide and lanreotide: used to treat a rare disorder characterised by excessive production of growth hormone (acromegaly). These medicines may increase or decrease your blood sugar levels.
Pioglitazone: oral anti-diabetic used to treat type 2 diabetes mellitus. Some patients with type 2 diabetes mellitus of long standing and heart disease or previous stroke who were treated with pioglitazone and insulin developed heart failure. Tell your doctor immediately if you have signs of heart failure such as unusual shortness of breath, rapid weight gain or localised swelling (oedema).
If you are in any of these situations (or are unsure), talk to your doctor, pharmacist or nurse.
Using Ryzodeg with alcohol
If you drink alcohol, it may alter your insulin need, as your blood sugar level may increase or decrease. Therefore, you should check your blood sugar level more often than usual.
Pregnancy and breast-feeding
It is not known if Ryzodeg affects the unborn child or breast-feeding. If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before using this medicine. You may need to adjust your insulin dose during pregnancy and after delivery. During pregnancy, it is essential to maintain good control of your diabetes to prevent complications in the mother and the unborn child.
Driving and using machines
A low or high blood sugar level may affect your ability to drive or use machines. If your blood sugar level is too low or too high, your concentration and reaction time may be impaired. This could put you or others at risk. Ask your doctor if you can drive:
Important information about some of the ingredients of Ryzodeg
This medicine contains less than 1 mmol of sodium (23 mg) per dose, which is essentially “sodium-free”.
Follow exactly the instructions for administration of this medicine given by your doctor. If you are not sure, talk to your doctor, pharmacist or nurse.
If you are blind or have reduced vision and cannot read the dose counter on the pen, do not use this pen without help. Ask for assistance from a person with good eyesight who is trained in the use of the pre-filled FlexTouch pen.
The pre-filled pen can deliver a dose of 1-80 units in one injection, in increments of 1 unit.
Your doctor will decide with you:
Flexibility in administration schedule
Depending on your blood sugar level, your doctor may change your dose.
When using other medicines, ask your doctor if you need to adjust your treatment.
Use in elderly (≥ 65 years old)
Ryzodeg can be used in elderly people, but you may need to check your blood sugar level more often. Talk to your doctor about possible changes in your dose.
If you have kidney or liver problems
If you have kidney or liver problems, you may need to check your blood sugar level more often. Talk to your doctor about possible changes in your dose.
Injecting the medicine
Before using Ryzodeg for the first time, your doctor or nurse will show you how to use the pre-filled pen.
Do not use Ryzodeg
How to inject
Detailed instructions for use are given on the other side of this leaflet.
If you use more Ryzodeg than you should
If you use too much insulin, your blood sugar level may become too low (hypoglycaemia), see the advice in section 4 “Low blood sugar level”.
If you forget to use Ryzodeg
If you miss a dose, inject the missed dose with the next main meal of the day and then continue with your regular dosing schedule. Do not inject a double dose to make up for a missed dose.
If you stop using Ryzodeg
Do not stop using your insulin without talking to your doctor first. Stopping your insulin injections could lead to a very high blood sugar level and diabetic ketoacidosis (a condition caused by too much acid in the blood), see the advice in section 4 “High blood sugar level”.
Like all medicines, this medicine can cause adverse effects, although not all people suffer from them.
When being treated with insulin, hypoglycemia (blood sugar level too low) may appear very frequently (it can affect more than 1 in 10 people). It can be very serious. If your blood sugar level decreases too much, you may lose consciousness. Severe hypoglycemia can cause brain damage and put your life at risk. If you have symptoms of low blood sugar, take measures to increase your blood sugar level immediately. See the tips on "Blood sugar level too low".
If you suffer a severe allergic reaction (rarely appears) to insulin or any of the components of Ryzodeg, stop treatment with this medicine and consult your doctor immediately. The signs of a severe allergic reaction are:
Other adverse effects include:
Frequent(may affect up to 1 in 10people)
Local reactions: localized reactions may appear at the injection site. Symptoms may include: pain, redness, hives, inflammation, and itching. These reactions usually disappear after a few days. If the symptoms do not disappear after a few weeks, consult your doctor. If the reactions worsen, stop treatment with Ryzodeg and consult your doctor immediately. For more information, see "severe allergic reaction" above.
Infrequent(may affect up to 1 in 100people)
Joint inflammation: when starting to use the medicine, the body may retain more fluid than it should. This causes inflammation of the ankles and other joints. This effect usually disappears quickly.
Rare(may affect up to 1 in 1,000people)
This medicine may cause allergic reactions such as hives, swelling of the tongue and lips, diarrhea, nausea, fatigue, and itching.
Frequency not known(cannot be estimated from the available data)
Changes in the skin at the injection site: If insulin is injected in the same place, the fatty tissue can shrink (lipoatrophy) or become thicker (lipohypertrophy). Lumps under the skin can also occur due to the accumulation of a protein called amyloid (cutaneous amyloidosis). Insulin may not work very well if injected into a bulging, thinned, or thickened area. Change the injection site with each injection to help avoid these skin changes.
General effects of diabetes treatment
Low blood sugar levels may appear if:
you drink alcohol, inject too much insulin, do more exercise than usual, eat very little, or skip a meal.
The warning symptoms of a blood sugar level that is too low may appear suddenly and are:
Headache, difficulty speaking, palpitations, cold sweat, cool and pale skin, dizziness, excessive hunger, tremors, nervousness or concern, fatigue, weakness, and unusual drowsiness, confusion, difficulty concentrating, temporary changes in vision.
What to do if your blood sugar level is too low
What others should do if you lose consciousness
Inform the people you spend time with that you have diabetes. Tell them what the consequences might be due to a drop in blood sugar level, including the risk of losing consciousness.
Tell them that if you become unconscious, they should do the following:
You may regain consciousness more quickly if you receive glucagon. This should only be administered by someone who knows how to do it.
Talk to your doctor if:
You may need to adjust the amount or administration schedule of insulin, food, or exercise.
High blood sugar levels may appear if:
you eat more or do less exercise than usual, drink alcohol, have an infection or fever, do not inject enough insulin, repeatedly inject less insulin than you need, forget to inject insulin, or interrupt treatment with insulin without talking to your doctor.
The warning symptoms of a blood sugar level that is too high usually appear gradually and are:
Dry and reddened skin, drowsiness or fatigue, feeling of dryness in the mouth, fruity breath odor (acetone), increased need to urinate, thirst, loss of appetite, nausea or feeling of discomfort (vomiting).
These can be symptoms of a very serious disorder called ketoacidosis. It is an accumulation of acid in the blood because the body metabolizes fat instead of sugar. If left untreated, it can lead to diabetic coma and death.
What to do if your blood sugar level is too high
Reporting adverse effects
If you experience any type of adverse effect, consult your doctor, pharmacist, or nurse, even if it is a possible adverse effect that is not listed in this prospectus. You can also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiration date that appears on the label and on the box of the pen after CAD. The expiration date is the last day of the month indicated.
Before first use
Store in the refrigerator (between 2 °C and 8 °C). Do not freeze. Do not store near the refrigeration element. Keep the pen with the cap on to protect it from light.
Once opened or if carried as a spare
You can carry your preloaded Ryzodeg (FlexTouch) pen with you and store it at room temperature (not above 30 °C) or in the refrigerator (between 2 °C and 8 °C) for 4 weeks.
Always keep the pen with the cap on when not in use to protect it from light.
Medicines should not be disposed of through wastewater or household waste. Ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.
Composition of Ryzodeg
Appearance of the Product and Container Content
Ryzodeg is presented as a clear and colorless injectable solution in a pre-filled pen (300 units per 3 ml).
Container sizes of 1 (with or without needles), 5 (without needles), and a multiple container of 10 (2 x 5) (without needles) pre-filled 3 ml pens.
Only some container sizes may be marketed.
Marketing Authorization Holder
Novo Nordisk A/S
Novo Allé
DK-2880 Bagsværd, Denmark
Manufacturer
Novo Nordisk A/S
Novo Allé
DK-2880 Bagsværd
Denmark
Novo Nordisk Production SAS
45, Avenue d’Orléans
28000 Chartres
France
Date of Last Revision of this Leaflet:
Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu
Instructions for Use of Ryzodeg 100 units/ml FlexTouch Solution for Injection in Pre-filled Pen
Read these instructions carefully before using your pre-filled pen.
If you do not follow the instructions carefully, you may administer too little or too much insulin, which could lead to high or low blood sugar levels.
Do not use the pen without proper trainingfrom your doctor or nurse.
Start by checking the pen to make sure it contains Ryzodeg 100 units/mland then look at the illustrations to familiarize yourself with the different parts of the pen and needle.
If you are blind or have reduced vision and cannot read the dose counter on the pen, do not use this pen without help.Seek help from a person who can see well and is trained in the use of the pre-filled FlexTouch pen.
Your pen is a pre-filled insulin doser that contains 300 units of insulin. You can select a maximum of 80 unitsper administration, in increments of 1 unit. The pen is designed to be used with disposable NovoTwist or NovoFine needles up to 8 mm in length for single use.
Pay special attention to these notes because they are important for the correct use of the pen.
1 Preparation of the Pen
Look through the insulin window. If the insulin appears cloudy, do not use the pen.
A drop of insulin may appear at the tip of the needle. This is normal, but you must still check the insulin flow.
Always use a new needle for each injection.
This reduces the risk of contamination, infection, loss of insulin, needle blockage, and inaccurate dosing.
Never use bent or damaged needles.
2 Checking the Insulin Flow
Gently tap the top of the pena few times to make any air bubbles rise.
The 0 should line up with the dose marker.
A drop of insulin should appear at the tip of the needle.
A small air bubble may remain at the tip of the needle, but it will not be injected.
If no drop appears,repeat steps 2A to 2C up to 6 times. If still no drop appears, change the needle and repeat steps 2A to 2C once more.
If, despite this, no insulin drop appears,discard the pen and use a new one.
Always make sure a drop appearsat the tip of the needle before injecting. This ensures the insulin is flowing.
If no drop appears, do notinject, even if the dose counter moves. This may indicate the needle is blocked or damaged.
Always check the flow before injecting.If you do not check the flow, you may receive too little or no insulin, which could lead to high blood sugar levels.
3 Selecting the Dose
The 0 should line up with the dose marker.
If you have selected a wrong dose, you can turn the dose selector forward or backward until you select the correct dose.
The pen can select up to a maximum of 80 units.
The dose selector changes the number of units. Only the dose counter and dose marker show how many units you have selected for each administration.
You can select up to 80 units for each administration. When the pen contains less than 80 units, the dose counter stops when it reaches the number of units left.
The dose selector clicks differently when turned forward, backward, or when passing the number of units left. Do not count the pen clicks.
Before injecting the insulin, always use the dose counter and dose marker to see how many units you have selected.
Do not count the pen clicks. If you select a wrong dose and inject it, your blood sugar level may become too high or too low. Do not use the insulin scale, as it only shows the approximate amount of insulin left in the pen.
4 Injecting the Dose
Do not touch the dose counter with your fingers. This could interrupt the injection.
The 0 should line up with the dose marker.
You may hear or feel a click.
If blood appears at the injection site, press lightly with a cotton swab. Do not rub the area.
A drop of insulin may appear at the tip of the needle after the injection. This is normal and does not affect the dose.
Always check the dose counter to see how many units you inject.
The dose counter shows the exact number of units. Do not count the pen clicks.
Keep the dose button pressed until the dose counter returns to 0 after the injection. If the dose counter stops before reaching 0, the full dose has not been administered, which could result in high blood sugar levels.
5 After the Injection
Always discard the needle after each injectionin an appropriate sharps container. This reduces the risk of contamination, infection, loss of insulin, needle blockage, and inaccurate dosing. If the needle is blocked, do notinject insulin.
When the pen is empty, discard it withoutthe needle attached, following the instructions of your doctor, nurse, pharmacist, or local authorities. Do not throw away the used needle in household waste.
Never try to put the inner needle cap back on.You could prick yourself with it.
Always remove the needle after each injectionand store your pen without the needle attached.
This reduces the risk of contamination, infection, loss of insulin, needle blockage, and inaccurate dosing.
6 How Much Insulin is Left?
Turn the dose selector until the dose counterstops.
If it shows 80, it means there are at least 80units left in the pen.
If it shows less than 80, the number indicates the amount of units left in the pen.
In case of doubt, inject the full dose with a new pen. If you incorrectly split the dose, you may inject too little or too much insulin, which could lead to high or low blood sugar levels.
More Important Information
Care of the Pen
Treat your pen with care. Rough handling or misuse can cause inaccurate dosing, which could lead to high or low blood sugar levels.
If you drop the pen or suspect it may have a problem, put a new needle on and check the insulin flow before injecting.